FaviƩ, Laurent M. A.
Peeters-Scholte, Cacha M. P. C. D.
Bakker, Anouk
Tjabbes, Huibert
Egberts, Toine C. G.
van Bel, Frank
Rademaker, Carin M. A.
Vis, Peter
Groenendaal, Floris
Article History
Received: 1 February 2020
Accepted: 8 February 2020
First Online: 19 February 2020
Competing interests
: C.M.P.C.D.P.-S., F.v.B. and F.G. are the inventors of 2-iminobiotin as a neuroprotective agent in neonates with hypoxic-ischemic encephalopathy. C.M.P.C.D.P.-S. and H.T. are shareholders and consultants of Neurophyxia BV. P.V. is employed at LAP&P Consultants BV. All other authors declare no conflicts of interest.